Search results

Jump to navigation Jump to search

Page title matches

Page text matches

  • {{rpl|Diabetes mellitus type 2}}
    737 bytes (105 words) - 04:07, 24 September 2013
  • ...d test used to monitor the treatment of [[diabetes mellitus type 1]] and [[diabetes mellitus type 2]].
    144 bytes (19 words) - 08:39, 22 June 2008
  • {{r|Diabetes mellitus type 2}} {{r|Diabetes mellitus type 2}}
    312 bytes (37 words) - 12:01, 1 September 2024
  • #REDIRECT [[Diabetes mellitus type 2]]
    38 bytes (4 words) - 18:29, 19 March 2010
  • #Redirect [[Diabetes mellitus type 2]]
    38 bytes (4 words) - 11:40, 14 May 2008
  • {{r|Diabetes mellitus type 2}} {{r|Diabetes mellitus type 2}}
    631 bytes (78 words) - 17:01, 21 August 2024
  • {{r|Diabetes mellitus type 2}}
    757 bytes (92 words) - 17:00, 6 August 2024
  • ...abolic risk factors for [[vascular disease|cardiovascular disease]]s and [[Diabetes mellitus type 2|type 2 diabetes mellitus]]. The major components of metabolic syndrome x in
    660 bytes (75 words) - 07:01, 18 September 2024
  • ...f lesser risk than [[Impaired glucose tolerance]] (IGT). IFG may precede [[Diabetes mellitus type 2]] by many years. IFG is also a risk factor for mortality.<ref name="pmid175 ...ly raised [[fasting]] [[glucose]] level, but less than would qualify for [[Diabetes mellitus type 2]]. On challenging with an [[oral glucose tolerance test]], normal blood glu
    2 KB (251 words) - 12:00, 31 August 2024
  • {{r|Diabetes mellitus type 2}}
    639 bytes (81 words) - 17:00, 6 August 2024
  • {{r|Diabetes mellitus type 2}}
    754 bytes (96 words) - 17:00, 6 August 2024
  • '''Hyperglycemic hyperosmolar nonketotic coma''' is a complication of [[diabetes mellitus type 2]].
    663 bytes (74 words) - 08:05, 17 October 2011
  • ...stance]] and increased risk of cardiovascular pathology. IGT may precede [[Diabetes mellitus type 2]] by many years. IGT is also a risk factor for mortality.<ref name="pmid17
    2 KB (223 words) - 12:00, 31 August 2024
  • {{r|Diabetes mellitus type 2}}
    898 bytes (111 words) - 19:11, 11 January 2010
  • ...of its blood-pressure-lowering effect in patients with [[hypertension]], [[Diabetes mellitus type 2|type 2 diabetes]], and nephropathy."<ref name="pmid18525041">{{cite journal
    1 KB (132 words) - 01:22, 15 June 2008
  • {{r|Diabetes mellitus type 2}}
    943 bytes (117 words) - 17:00, 6 August 2024
  • {{r|diabetes mellitus type 2}}
    974 bytes (151 words) - 12:01, 22 August 2024
  • {{r|Diabetes mellitus type 2}} {{r|Diabetes mellitus type 2}}
    1 KB (185 words) - 12:01, 30 August 2024
  • {{r|Diabetes mellitus type 2}}
    2 KB (198 words) - 09:10, 19 September 2024
  • ...' ('''UKPDS''') is a [[randomized controlled trial]] of the treatment of [[diabetes mellitus type 2]].<ref name="pmid9742976">{{cite journal |author= |title=Intensive blood-g
    3 KB (406 words) - 10:17, 12 December 2011
View (previous 20 | ) (20 | 50 | 100 | 250 | 500)